PRIMARY CONTAINER TYPE | AMPUL |
PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND |
| 7.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
ADMINISTRATION | INTRAVENOUS |
TOTAL PRIMARY CONTAINER QUANTITY | 25 |
SPECIAL FEATURES | 5% LIDOCAINE HYDROCHLORIDE AND 7.5% DEXTROSE INJECTION, USP CONTAINS 50 MG/ML OF LIDOCAINE HYDROCHLORIDE, ANHYDROUS WITH 75 MG/ML OF DEXTROSE, HYDROUS IN WATER FOR INJECTION. STORE AT 20-25 DEG C(68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) |
PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION USP 2ML AMPUL 25S |